SCTX · Scribe Therapeutics, Inc. · Congressional Trades
$17.10
+0.90 (+5.56%)
At close · Nov 4
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 2, 2026
The latest filing states the doubt was alleviated.
“Substantial doubt about our ability to continue as a going concern existed as of June 30, 2026 and was alleviated as a result of the completion of our initial public offering and concurrent private placement, which resulted in aggregate net proceeds of approximately $140.7 million.”View the 10-Q filed Sep 2, 2026
Market Cap
$320.27M
Shares
18.93M
Volume · Nov 4
204.81K
Avg daily vol (3M)
375.75K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.